Total Funding
61
Total FundingSeries B raised
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Bioarray Therapeutics is a biotech company that is committed to transforming cancer treatment decisions and outcomes using gene profiling.
Katherine Martin: Founder and CSO
About the Company
BIOARRAY's Therapeutics, Inc. (BIOARRAY) is a privately held start up biotechnology company founded in 2009 in Boston, MA.
BIOARRAY is developing proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach
currently used.
Hispanic / Latine Founded
Women Founded
